|
|
|
|
| AI and machine learning are the buzzwords of the decade, often accompanied by lofty promises — but what do they really mean for biopharma? How can these technologies be adopted to improve biomanufacturing processes, testing, and quality? Join Bioprocess Online Live for an exploration into the practical applications of AI/ML in biomanufacturing, its barriers to adoption, and how regulators can help standardize use across the industry. Registration is free thanks to the support of Atum Bio. |
|
|
FOCUS ON FACILITIES DESIGN |
|
|
|
By Matthew Pillar, Editor, Bioprocess Online
| I had the opportunity to cover a lot of ground on considerations for single-use technologies in biopharmaceutical manufacturing with Mark Petrich, Ph.D. when he joined me as a guest expert on the Bioprocess Online Live event Single Use Technologies For Bioprocessing: An Essential Update. Here are some of his insights on single-use scale and lifecycle management. |
|
|
| Steps For Proper Cleaning Validation | e-book | By Michael Moussourakis, Jeff Phillips, Stacy Silverstein, and Malcolm McLaughlin, Alconox Inc. | Examine the steps of cleaning validation for both low-volume and high-volume manufacturers and the important role these studies play. |
|
|
|
|
|
FACILITIES DESIGN SOLUTIONS |
|
|
|
|
|
|
| The Allogeneic Future with Poseida's Kristin Yarema, Ph.D. | Kristin Yarema, Ph.D. says CAR T-cell therapies have to become a one-to-many proposition, if their early autologous success can live up to the promise of offering widespread accessibility to life-saving treatments. On the Business of Biotech, we learn how the newly appointed CEO of Poseida Therapeutics is positioning the company to crack the allogeneic CAR T code and how strategic collaborations with the likes of Astellas and Roche are fueling the effort. |
|
|
FOCUS ON PROCESS ENGINEERING |
|
|
|
A conversation with Matt Foster, Darragh McDonagh, and Kevin Seibert, Eli Lilly and Company | Three company leaders answer questions about the IE2b project, which is receiving an ISPE 2024 Facility of the Year Award for its ingenuity of complexity. |
|
|
| A Focus On Cell Therapy: CAR-T, CAR-NK, And Beyond | Article | By Tae Whan Kim, GC Cell | As the landscape of CAR T-cell therapies evolves, these treatments are becoming more precise in targeting cancer cells and overcoming production challenges, and are poised to revolutionize oncology. |
|
|
|
| The High Cost Of Going Cheap | Article | By Jessica Carmen, Ph.D., Kincell Bio | Developers often aim to cut expenses during development. Discover the long-term outcomes of cost-effective measures like using RUO leukopaks compared to investing in high-quality GMP-grade vectors. |
|
|
| Accelerate Your R&D And QC With These 3 Key Analysis Methods | Article | By Monika Schennen, Julienne Regele, Calliste Scholl, and Morgan Ulrich, TA Instruments | Learn about three key thermal analysis methods for fast and effective characterization and quality control: differential scanning calorimetry, thermogravimetric analysis, and sorption analysis. |
|
|
|
|
| AAV Titer Estimation With Mass Photometry | Application Note | Refeyn | How do new mass photometers, featuring a new titer estimation tool, perform as a powerful analysis technique when used to evaluate the quality of AAV samples. |
|
|
|
|
|
|
|
|
|
|
|
| Speeding-Up Analysis And Fast-Tracking mRNA Development | Article | Danaher Life Sciences | mRNA therapeutics have the potential to address a variety of diseases, and understanding mRNA molecules and access faster analytical solutions are crucial elements for the rapid development of these therapies. |
|
|
|
PROCESS ENGINEERING SOLUTIONS |
|
|
|
|
|
|
Connect With Bioprocess Online: |
|
|
|